IF: 0.644
REUTERS THOMSON

The Prevalence and Clinical Significance of Anticardiolipin Antibody in Acute Myeloblastic Leukemia

AUTHORS

M Ramzi 1 , * , M Ayatollahi 2 , J Tahmasebi 2 , N Cohan 2

1 Associate Professor of Hematology Research Center, Shiraz University of Medical Sciences, ramzim@sums.ac.ir, Fars, Iran

2 Stem Cell and Transgenic Technology Research Center, Hematology Research Center, Transplant Research Center, Shiraz University of Medical Sciences, Fars, Iran

How to Cite: Ramzi M, Ayatollahi M, Tahmasebi J, Cohan N. The Prevalence and Clinical Significance of Anticardiolipin Antibody in Acute Myeloblastic Leukemia, Iran Red Crescent Med J. Online ahead of Print ; 12(5):564-567.

ARTICLE INFORMATION

Iranian Red Crescent Medical Journal: 12 (5); 564-567
Article Type: Research Article
Received: February 27, 2010
Accepted: May 24, 2010

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Antiphospholipid antibodies, including lupus anticoagulants and anticardiolipin (aCL) antibodies are associated with a wide variety of disorders including malignancies. The aim of this study was to investigate the prevalence and prognostic significance of aCL antibodies in Iranian patients with acute myeloblastic leukemia (AML).

 

Methods: Forty-one patients with AML (27 men and 14 women, mean age 34.9±16.7 years) were included in this study. aCL IgG and aCL IgM antibodies were evaluated in patients before induction chemotherapy. All patients were followed up for chemotherapy response.

 

Results: Antibodies (IgG, IgM or both) were found in 26 of 41 patients (63.4%), of whom 19 (46.3%) had a low titer, 6 (14.6%) a moderate titer and 1 (2.4%) a high antibody titer. No correlation was found between complete remission or relapse and aCL antibodies positivity.

 

Conclusion: aCL antibody titers are slightly to moderately elevated in patients with hematologic malignancies, and these antibodies do not correlate with disease prognosis.

Keywords

Anticardiolipin antibody Acute myeloblastic leukemia Clinical significance Iran

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: